National Treatment Purchase Fund

3298. Deputy Pádraig O'Sullivan asked the Minister for Health the criteria and methodology used by the National Treatment Purchase Fund in negotiating prices with private and voluntary nursing homes under the nursing homes support scheme; and if she will make a statement on the matter. [55711/26]

3299. Deputy Pádraig O'Sullivan asked the Minister for Health the average weekly price negotiated by the National Treatment Purchase Fund with private and voluntary nursing homes under the nursing homes support scheme; the average weekly cost of care in a public nursing home, in each of the years 2021, 2022, 2023, 2024, 2025 and to date in 2026, in tabular form; and if she will make a statement on…

3301. Deputy Pádraig O'Sullivan asked the Minister for Health when the review of the pricing system used by the National Treatment Purchase Fund to negotiate prices with private and voluntary nursing homes under the nursing homes support scheme will be published; the reason for the delay beyond the programme for Government commitment to publish it in early 2025; and if she will make a statement on…

863. Deputy Ken O'Flynn asked the Minister for Health whether she accepts that confirmation of no clinical audits since 2020 represents a governance gap in the Treatment Abroad Scheme; and the steps she will take to close it. [49309/26]

522. Deputy Marie Sherlock asked the Minister for Health the number of people who have used the cross-border directive for Lyme’s disease, or conditions associated with it, because of an absence of appropriate care here in Ireland, for the years 2020 to 2025. [46672/26]

2153. Deputy Duncan Smith asked the Minister for Health if she will urgently examine the application for the national treatment purchase fund for a person (details supplied); if the application will be expedited; and if she will make a statement on the matter. [42998/26]

1365. Deputy Ruth Coppinger asked the Minister for Health the supports available for a person (details supplied) to gain access to surgery aboard given issues that have been raised; and if she will make a statement on the matter. [39509/26]

1371. Deputy Erin McGreehan asked the Minister for Health to detail the process and eligibility criteria for patients accessing treatment through the National Treatment Purchase Scheme; and to provide the number of applications, approvals, refusals and reimbursements under the scheme in each of the past three years, as well as any planned changes or improvements. [39555/26]

1372. Deputy Erin McGreehan asked the Minister for Health to outline the full process and eligibility criteria for patients applying under the Treatment Abroad Scheme; and to provide the number of applications, approvals, refusals and reimbursements issued under the scheme in each of the past three years, together with any planned changes or improvements. [39556/26]

1419. Deputy Ken O'Flynn asked the Minister for Health whether any national reporting mechanism exists for adverse incidents, safeguarding concerns, regret outcomes or complaints associated with minors referred abroad under publicly funded healthcare pathways. [39778/26]

1420. Deputy Ken O'Flynn asked the Minister for Health whether any standardised post-treatment follow-up protocol applies to minors returning to Ireland following healthcare treatment, assessment or intervention abroad funded directly or indirectly by the State. [39779/26]

1421. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE maintains any national estimate of the number of minors currently engaged in overseas healthcare pathways supported directly or indirectly through public funding arrangements. [39780/26]

567. Deputy Ken O'Flynn asked the Minister for Health whether any monetary approval thresholds exist within the treatment abroad scheme requiring additional sign-off for high-cost procedures; the officials or grades responsible for such approvals; and if she will provide the thresholds currently applied. [36018/26]

568. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates any formal value-for-money assessment process prior to approving exceptionally high-cost procedures abroad; and if so, the methodology used. [36019/26]

569. Deputy Ken O'Flynn asked the Minister for Health the number of Treatment Abroad Scheme applications approved with an estimated cost exceeding in each year since 2020 (details supplied). [36020/26]

570. Deputy Ken O'Flynn asked the Minister for Health whether any applications under the Treatment Abroad Scheme have been refused wholly or partly on financial, budgetary, or proportionality grounds since 2020; and if she will provide annual figures. [36021/26]

571. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost overseas procedures approved under the Treatment Abroad Scheme; and if so, the governance and reporting arrangements applying to that register. [36022/26]

572. Deputy Ken O'Flynn asked the Minister for Health the dates of all internal audit reviews, Comptroller and Auditor General examinations, or other formal oversight reviews conducted in respect of the Treatment Abroad Scheme since 2020; and if copies of findings or recommendations will be provided. [36023/26]

573. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been conducted regarding financial exposure arising from exceptionally high-cost procedures funded under the Treatment Abroad Scheme; and if so, whether she will provide details. [36024/26]

574. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme has any specific governance pathway for novel, experimental, or highly specialised procedures abroad involving significant State expenditure. [36025/26]

575. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme maintains procedure-specific coding or categorisation for any surgical specialties funded abroad; and if so, to provide the categories recorded. [36026/26]

576. Deputy Ken O'Flynn asked the Minister for Health whether the HSE is capable of identifying retrospectively the categories of gender affirmation procedures funded under the Treatment Abroad Scheme through MDT reports, referral documentation, consultant submissions, or reimbursement records. [36027/26]

577. Deputy Ken O'Flynn asked the Minister for Health whether any legal, GDPR, administrative, or policy barrier prevents the Treatment Abroad Scheme from recording anonymised procedure-category data for overseas gender-related surgeries. [36028/26]

578. Deputy Ken O'Flynn asked the Minister for Health whether the Internal Audit Office of the HSE or the Comptroller and Auditor General has ever examined governance, expenditure tracking, safeguarding, or procedure categorisation relating to overseas gender affirmation surgery referrals under the Treatment Abroad Scheme. [36029/26]

579. Deputy Ken O'Flynn asked the Minister for Health whether her Department has requested the introduction of structured reporting or coding mechanisms relating to gender affirmation procedures funded abroad under the Treatment Abroad Scheme. [36030/26]